The metabolism and disposition of D-penicillamine in the DA-strain rat
- PMID: 3208797
- DOI: 10.1007/BF03191310
The metabolism and disposition of D-penicillamine in the DA-strain rat
Abstract
Radiolabelled [35S]-D-penicillamine was administered orally to DA-strain rats. After 72 hours approximately 65% of the dose was excreted with no significant differences between male and female animals. The major urinary product was inorganic sulphate with small amounts of D-penicillamine. Penicillamine disulphide, penicillamine-cysteine, S-methyl penicillamine and N-acetyl penicillamine were also found as metabolites. The female rat excreted significantly less sulphate (P less than 0.1) and more penicillamine disulphide (P less than 0.01) than the male. The residual radioactivity was found in the carcass, with slight concentration in the gut, skin, kidney, bladder and liver.
Similar articles
-
The metabolism of 35S-D-penicillamine in man.Xenobiotica. 1988 Feb;18(2):235-44. doi: 10.3109/00498258809041659. Xenobiotica. 1988. PMID: 3376495
-
An outline of D-penicillamine metabolism.Proc R Soc Med. 1977;70 Suppl 3(Suppl 3):61-4. doi: 10.1177/00359157770700S321. Proc R Soc Med. 1977. PMID: 122676 Free PMC article.
-
D-penicillamine metabolism: in vitro studies of S-oxidation mechanisms.Drug Metabol Drug Interact. 1988;6(1):85-93. Drug Metabol Drug Interact. 1988. PMID: 3234004
-
The metabolism and pharmacology of D-penicillamine in man.J Rheumatol Suppl. 1981 Jan-Feb;7:41-50. J Rheumatol Suppl. 1981. PMID: 7014876 Review.
-
Clinical pharmacokinetics of D-penicillamine.Clin Pharmacokinet. 1987 Nov;13(5):317-33. doi: 10.2165/00003088-198713050-00003. Clin Pharmacokinet. 1987. PMID: 3319347 Review.
Cited by
-
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivo.Drug Metab Dispos. 2012 Dec;40(12):2315-23. doi: 10.1124/dmd.112.046821. Epub 2012 Sep 4. Drug Metab Dispos. 2012. PMID: 22949627 Free PMC article.